Page last updated: 2024-10-22

albuterol and Consciousness, Loss of

albuterol has been researched along with Consciousness, Loss of in 2 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dimond, JP1
Palazzo, MG1
Löwhagen, O1
Ekström, L1
Holmberg, S1
Wennerblom, B1
Rosenfeldt, M1

Other Studies

2 other studies available for albuterol and Consciousness, Loss of

ArticleYear
An unconscious man with asthma and a fixed, dilated pupil.
    Lancet (London, England), 1997, Jan-11, Volume: 349, Issue:9045

    Topics: Albuterol; Asthma; Brain Edema; Bronchodilator Agents; Carbon Dioxide; Humans; Hypoxia; Intracranial

1997
Experience of an emergency mobile asthma treatment programme.
    Resuscitation, 1997, Volume: 35, Issue:3

    Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Albuterol; Ambulances; Asthma; Broncho

1997